Shameze Rampertab

All filings by Shameze Rampertab on record concern Zomedica Pharmaceuticals Corp. Over a trading history stretching from 21 April 2016 to 8 January 2018, the count stands at 8 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 9 January 2018: an option exercise of €21k, in Zomedica Pharmaceuticals Corp. Typically, a trade is published a median of 7 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.